Elez E, Cubillo A, Alfonso PG, Middleton MR, et al. Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study. BMC Cancer 2024;24:446.
PMID: 38600471